Abstract Article

research6

Design and Optimization of Lamivudine Floating Microspheres

Pandey GK*, Pandey D, Jain D, Joshi A, Dubey BK

ONLINE ISSN : 2456-8244


INSTRUCTIONS TO AUTHORS

ABSTRACT

The present study was focused to develop floating microspheres of Lamivudine in order to achieve an extended retention in the upper gastrointestinal tract, which may result in enhanced absorption and thereby improved bioavailability. The present study involves preparation and evaluation of floating microspheres using Lamivudine as a model drug for prolongation of the gastric retention time. As Lamivudine is mainly absorbed from stomach, thus using floating microspheres as a mode of drug delivery helps in increasing its residence time and hence increasing the bioavailability of drug. The microspheres were prepared by the Ionic gelation method. The average diameter and surface morphology of the prepared microspheres were characterized by optical microscope and scanning electron microscopic methods respectively. The prepared microspheres were evaluated for particle size, micromeritic study, drug entrapment efficiency, in vitro buoyancy, swelling index and in vitro release. The effect of various formulation variables on the size and drug release was also investigated. All the formulated microspheres were found to possess good flow properties. Scanning electron microscopy confirmed spherical structure of the prepared microspheres. The best formulation F3 drug release kinetics were evaluated using Zero order, First order, Higuchi model, Korsmeyer - Peppas model. After the interpretation of data that was based on the value of a resulting regression coefficient, it was observed that the Korsmeyer- Peppas model has a highest regression coefficient values indicating that the drug release was based on the erosion of polymeric chain matrix system

KEYWORDS

Lamuvudine, Floating microspheres, Gum acacia, Zero order, First order, Higuchi model, Korsmeyer-Peppas model

DOI

REFERENCES

Aulton, M. E., 2002. Pharmaceutics: The Science of Dosage Form Design. 2nd ed., Livingstone C. Elsevier science Ltd. Dubey M, Kesharwani P, Tiwari A, Chandel R, Raja K, Sivakumar T. Formulation and Evaluation of Floating Microsphere Containing Anti Diabetic Drug. Internat J Pharm Chem Sci 2012; 3: 1038-1047. Freiberg S. Polymer microspheres for controlled drug release. XX. Internat J Pharm 2004; 282 (1-2):1–18. Gangadharappa HV, Biswas S, Getyala A, Vishal N, Gupta PK. Development, in- vitro and in-vivo Evaluation of Novel Floating. Der Pharmacia Lettre 2011; 3 (4): 299-316. Jamadar SA, Snehal P, Mulye K, Poonam S, Pore YV, Burade KB. Development and validation of UV spectrophotometric method for the determination of Lamivudine in tablet dosage form. Scholars Research Library 2011; 3(4):338-343. Kokate, C.K., Purohit, A.P., Gokhale, S.B., 2010. Pharmacognosy. 45th ed., Nirali prakashan. pp 7.12-7.13. Pande AV, Vaidya PD, Arora A, Dhoka MV. In vitro and In vivo evaluation of ethyl cellulose based floating microspheres of cefpodoxime proxetil. Internat J Pharm Biomed Res 2010; 1(4): 122-128. Prak J, Ye M, Park K. Review Biodegradable Polymers for Microencapsulation of Drugs. Molecules 2005; 10 (1): 146-161. Prakash S, Bhandari A, Mishra R, Sharma PK. Development and optimization of floating microspheres of gliclazide. Internat J Pharm Sci Res 2015; 6(5): 807-817 Punitha K, Kadhir S, Umadevis K, Vaijayanti VS, Padma PS, Suresh K. Intragastric Floating Drug Delivery System Of Ranitidine Hydrochloride: Formulation And Evaluation. Internat J Pharm Pharm. Council 2010; 2(4): 975-1491. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. 6th edition. RPS publication 2009. Swarnkar K, Tanwar P, Sharma M, Singhal A, Sharma M, Ashish K Preparation and optimization of oral floating alginate gel beads of famotidine. IJPSRS 2012; 3(2):04-08. Tang YD, Venkatraman SS, Boey FYC, Wang Li-Wei. Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form. Int J Pharm 2007; 336: 159-165. Trivedi P, Verma ML, Garud N. Preparation and characterization of aceclofenac microspheres. Asian J Pharm 2008; 2: 110-115. Wilding IR, Davis SS, O’Hagan DT. Targeting of Drugs and Vaccines to the Gut. Pharmac Ther 1994; 98–124.